Choksi Laboratories Ltd
₹207.00▲ +4.65 (+2.30%)
CHOKSILA·BSE·Healthcare Services
Market Cap
125.50 Cr
PE Ratio
73.40
Volume
47,754
Day High - Low
212.45 - 194.00
52W High-Low
226.65 - 81.85
₹207.00▲ +4.65 (+2.30%)
Market Cap125.50 Cr
PE Ratio73.40
Volume47,754
Day High - Low212.45 - 194.00
52W High-Low226.65 - 81.85
Choksi Laboratories Ltd (CHOKSILA): company summary
The company's annual revenue rose 10.1% to ₹46 crore, while annual net profit increased 28.9% to ₹2 crore.
Choksi Laboratories Ltd (CHOKSILA) is a micro-cap Healthcare Services company valued at ₹126 crore operating in Healthcare Service Provider on the NSE and BSE.
- Recent price move
- Choksi Laboratories Ltd last traded at ₹207, up 2.30% on the day.
- Recent developments
- On 2026-09-30, foreign institutional holding increased by 2.99 percentage points to 10.01%, reflecting a shift in external investor positioning. On 2026-06-30, the company reported a net profit of ₹1 crore for the latest quarter, up from ₹0 crore in the same quarter a year earlier.
- Financial performance
- The company's annual revenue rose 10.1% to ₹46 crore, while annual net profit increased 28.9% to ₹2 crore. The latest quarter showed revenue up 7.3% year-on-year to ₹12 crore and net profit surged 48.7% to ₹1 crore, driven by improved profitability.
- Valuation multiples
- The stock trades at 73.4 times earnings, 4.96 times book value.
- Things to watch
- The company's profit growth over the past three years has declined by 15.2% annually, despite rising revenue. The stock is 10.7% below its 52-week high, and the company's return on equity remains at 7.7%, below the return on capital employed of 10.7%.
- Where it stands
- The company's latest quarter net profit rose 48.7% to ₹1 crore, while annual net profit increased 28.9% to ₹2 crore. The stock is 10.7% below its 52-week high, and the company's debt to equity ratio stands at 1.20.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
4.1/10
Weak
Fair Value
Sign in to see
ROE
7.68%
Weak
P/E
73.40x
Expensive
Debt / Equity
1.20
Elevated
Industry
Healthcare Services
Healthcare Service Provider
Overall View
Mixed
Price performance
Day₹194.00
₹212.45
52W₹81.85
₹226.65
DocStoX take
Supported by momentum (7.5) and risk (6.3), but held back by valuation (0.0). Momentum looks strong at 7.5, but that is offset by valuation at 0.0 and growth at 2.0. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidence4.1
/10
Weak
Quality
Solid
ROE 7.7%
Valuation
Expensive
P/E 73.4×
Growth
Flat
Revenue +12.4% 5Y CAGR
Risk
Moderate
D/E 1.20
Momentum
Strong
86% of 52-week range
At a glance
Market Cap
₹126 Cr
52W High / Low
₹227 / ₹82
Dividend Yield
0.00%
Promoter Holding
31.48%
EPS (TTM)
₹2.82
Book Value
₹36.72
Key highlights
- Profitable in all of the last 5 years
- Profit shrinking 15% a year
- Valuation is weak (0.0/10)
1 Positive4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare Services stocks · Healthcare Service Provider
Explore Choksi Laboratories Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Choksi Laboratories Ltd peers in Healthcare Services
Other Healthcare Services stocks on the NSE & BSE. See the full Healthcare Services sector list.
Related tools & concepts
Value Choksi Laboratories Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing